Omeros (OMER) Net Cash Flow (2010 - 2026)
Omeros (OMER) reported Net Cash Flow of -$7.8 million for Q1 2026, down 1000.58% on a YoY basis from $861000.0 in Q1 2025, and down 206.73% sequentially from $7.3 million in Q4 2025.
Omeros (OMER) Net Cash Flow (2010 - 2026) Analysis & Trends
Omeros (OMER) has 17 years of Net Cash Flow data on file, last reported at -$7.8 million in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow fell 1000.58% year-over-year to -$7.8 million; the trailing twelve-month figure through Mar 2026 stood at -$2.4 million (down 196.91% YoY), and the FY2025 full-year result was $6.3 million, up 268.96% from the prior year.
- Net Cash Flow retreated to -$7.8 million in Q1 2026, from $7.3 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $131.4 million in Q3 2022 to a low of -$134.5 million in Q4 2022.
- A 5-year average of -$5.8 million and a median of $289000.0 in 2024 frame the typical range for Net Cash Flow.
- Peak annual rise in Net Cash Flow reached 2585.28% in 2022, while the deepest fall reached 6135.23% in 2022.
- Tracing OMER's Net Cash Flow over 5 years: stood at -$134.5 million in 2022, then surged by 82.5% to -$23.5 million in 2023, then soared by 107.98% to $1.9 million in 2024, then jumped by 286.64% to $7.3 million in 2025, then slumped by 206.73% to -$7.8 million in 2026.
- Business Quant data shows OMER's Net Cash Flow at -$7.8 million in Q1 2026, $7.3 million in Q4 2025, and $491000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn | -7.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.75 Mn |
| Mar 31, 2026 | -7.75 Mn |
| Dec 31, 2025 | 7.27 Mn |
| Dec 31, 2025 | 7.27 Mn |
| Sep 30, 2025 | 491,000.00 |
| Sep 30, 2025 | 491,000.00 |
| Jun 30, 2025 | -2.36 Mn |
| Jun 30, 2025 | -2.36 Mn |
| Mar 31, 2025 | 861,000.00 |
| Mar 31, 2025 | 861,000.00 |
| Dec 31, 2024 | 1.88 Mn |
| Dec 31, 2024 | 1.88 Mn |
| Sep 30, 2024 | -599,000.00 |
| Sep 30, 2024 | -599,000.00 |
| Jun 30, 2024 | 289,000.00 |
| Jun 30, 2024 | 289,000.00 |
| Mar 31, 2024 | -5.27 Mn |
| Mar 31, 2024 | -5.27 Mn |
| Dec 31, 2023 | -23.54 Mn |
| Dec 31, 2023 | -23.54 Mn |